Mosunetuzumab Monotherapy Demonstrates Durable Efficacy with a Manageable Safety Profile in Patients with Relapsed/Refractory Follicular Lymphoma Who Received ≥2 Prior Therapies: Updated Results from a Pivotal Phase II Study

被引：24

作者：

Bartlett, Nancy L. ^{[1
]}

Sehn, Laurie H. ^{[2
,3
]}

Matasar, Matthew J. ^{[4
]}

Schuster, Stephen J. ^{[5
]}

Assouline, Sarit ^{[6
]}

Giri, Pratyush ^{[7
]}

Kuruvilla, John ^{[8
]}

Canales, Miguel ^{[9
]}

Dietrich, Sascha ^{[10
]}

Fay, Keith ^{[11
,12
]}

Ku, Matthew ^{[13
]}

Nastoupil, Loretta J. ^{[14
]}

Wei, Michael C. ^{[15
]}

Yin, Shen ^{[15
]}

To, Iris ^{[15
]}

Huang, Huang ^{[16
]}

Min, Juliana ^{[17
]}

Penuel, Elicia ^{[15
]}

Budde, L. Elizabeth ^{[18
]}

机构：

[1] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA

[2] BC Canc Ctr Lymphoid Canc, Vancouver, BC, Canada

[3] Univ British Columbia, Vancouver, BC, Canada

[4] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[5] Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USA

[6] McGill Univ, Jewish Gen Hosp, Montreal, PQ, Canada

[7] Royal Adelaide Hosp, Adelaide, SA, Australia

[8] Princess Margaret Canc Ctr, Toronto, ON, Canada

[9] Hosp Univ La Paz, Madrid, Spain

[10] Heidelberg Univ, Heidelberg, Germany

[11] St Vincents Hosp, Sydney, NSW, Australia

[12] Royal North Shore Hosp, Sydney, NSW, Australia

[13] Univ Melbourne, St Vincents Hosp, Melbourne, Vic, Australia

[14] MD Anderson Canc Ctr, Houston, TX USA

[15] Genentech Inc, San Francisco, CA 94080 USA

[16] F Hoffmann La Roche Ltd, Mississauga, ON, Canada

[17] Roche Prod Ltd, Welwyn Garden City, Herts, England

[18] City Hope Natl Med Ctr, Duarte, CA USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-157691

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1467 / 1470

页数：4